Latest

Latest Cambridge News | Page 21

  • Latest Cambridge news stories and updates. What is happening today? All recent Cambridge news and developments. Live coverage and timeline of Cambridge. All you need to know about Cambridge.
Six significant grants to solve world’s biggest killer – cardiovascular disease
How our genes influence our gut health
Male carriers of BRCA1 and BRCA2 gene mutation also at risk of multiple cancers: study
Is AI ageist? Researchers examine impact of technology on older users
David Williamson Receives 2022 Steele Prize from American Mathematical Society
As Omicron Cases Skyrocket, Extreme Marquees is Working on Medical Tents on War Footing
Bold bittern bucks trend, strikes pose in backyard
Imfinzi plus chemotherapy reduced risk of death by 20% in 1st-line advanced biliary tract cancer
Imfinzi plus tremelimumab demonstrated unprecedented survival in 1st-line unresectable liver cancer with 31% of patients alive
Development of fatty liver disease under healthy diet
Creating Reference Map to Explore Electronic Device Mimicking Brain Activity
AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment with practice-changing Imfinzi and Lynparza data
AstraZeneca and Scorpion Therapeutics enter agreement to discover, develop and commercialise novel cancer treatments against
Machine learning illuminates genetic links between blood cells and disease
AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to develop and commercialise NI006
Transfer of global rights for Eklira and Duaklir to Covis Pharma completed
Tokyo Tech Academy of Energy and Informatics holds online kick-off ceremony, workshop
New book upends thinking on why people have ‘bad beliefs’
AstraZeneca and Ionis close agreement to develop and commercialise eplontersen
Blueprint Reveals How Plants Build Sugar Transport Lane
Vaxzevria significantly boosted antibody levels against Omicron
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant 23 December
Ultomiris regulatory submission accepted under FDA Priority Review
Fourth man charged over abduction and home invasion at Sans Souci, NSW
Saphnelo recommended for approval in EU by CHMP for treatment of patients with systemic lupus erythematosus
Tezspire approved in US for severe asthma
NSW latest Covid update as at 17 December
Powerledger: world’s first ‘new energy’ trading platform
Police charge three people over deliberately lit fires in Snug and Cambridge
Funding helps projects spring into action
NSW latest public Health Alert – New venues of concern in Newcastle
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant
NSW latest Covid update as at 16 December
NSW latest public Health Alert – Venue of concern in Newcastle 16 December
LOGOS consortium completes landmark $1.67 billion acquisition of warehousing and property components of Qube’s Moorebank Logistics
Ashurst advises National Express on all-share combination with Stagecoach
CSL Committed to mRNA Program
NSW police lay charges after fatal crash
Understanding mass influence activities is critical
Evusheld long-acting antibody combination authorised for emergency use
Griffith Golden Key Scholarship recipients are all smiles
AstraZeneca and Ionis sign deal to develop and commercialise eplontersen
AstraZeneca reinforces leadership in breast cancer at SABCS 2021 with new data underscoring ambition to redefine cancer care
Caught on Camera: Live Imaging of Transcription Using Active RNA Polymerase II-Specific Probes
Delivering more local investment and jobs at Momentum Energy
Human Rights Council President appoints Lynn Welchman of United Kingdom to serve on Commission of Inquiry on Syrian Arab Republic
Lynparza granted Priority Review in US for BRCA-mutated HER2-negative high-risk early breast cancer
Eftpos flicks switch on world-class AI anti-fraud technology to fortify online shopping security

© 2026 - The National Tribune Australia